A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

Affiliations

Comment

Stefan Stojkovic et al. N Engl J Med. 2020.

. 2020 Jul 9;383(2):e8.

doi: 10.1056/NEJMc2017351.

¹ Medical University of Vienna, Vienna, Austria stefan.stojkovic@meduniwien.ac.at.

No abstract available

Comment in

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply.
Dangas GD, De Backer O, Windecker S. Dangas GD, et al. N Engl J Med. 2020 Jul 9;383(2):e8. doi: 10.1056/NEJMc2017351. N Engl J Med. 2020. PMID: 32640145 No abstract available.

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Clinical Trial.
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS, Veien KT, Abdel-Wahab M, Kim WK, Balan P, Van Mieghem N, Mathiassen ON, Jeger RV, Arnold M, Mehran R, Guimarães AHC, Nørgaard BL, Kofoed KF, Blanke P, Windecker S, Søndergaard L; GALILEO-4D Investigators. De Backer O, et al. N Engl J Med. 2020 Jan 9;382(2):130-139. doi: 10.1056/NEJMoa1911426. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733182 Clinical Trial.